Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine

BIOLOGICAL2 trials

Sponsors

Mayo Clinic

Conditions

Giant Cell GlioblastomaGlioblastomaGliosarcomaRecurrent GlioblastomaRecurrent Gliosarcoma

Early Phase 1

Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

CompletedNCT01957956

Mayo ClinicGiant Cell Glioblastoma, Glioblastoma, Gliosarcoma

Start: 2013-11-11End: 2016-11-16Updated: 2023-11-18

Vaccine Therapy in Treating Patients With Recurrent Glioblastoma

CompletedNCT03360708

Mayo ClinicGiant Cell Glioblastoma, Recurrent Glioblastoma, Recurrent Gliosarcoma

Start: 2013-11-27End: 2021-06-02Updated: 2023-06-28